The popularity of CBD, derived from cannabis, has been steadily growing in recent years. Many consumers use it for its wellness effects or as a natural remedy for certain ailments. However, when pregnancy or breastfeeding is involved, the question of CBD's safety takes on a whole new dimension. Many parents wonder about official recommendations, the potential risks for both mother and baby, and the current state of scientific knowledge. What do international health authorities say? What conclusions have been drawn from recent scientific studies on the subject?
What are the risks associated with using CBD during pregnancy and breastfeeding?
The introduction of CBD into lifestyles, particularly among pregnant or breastfeeding women, calls for a careful examination of the issues related to maternal and infant health. The debates focus on several key areas: the safety of CBD in relation to health standards, itspotential impact on infant development, and the lack of unanimous scientific consensus regarding its effects.
Although CBD is known not to produce a psychoactive effect, unlike THC, it remains an active component of cannabis that can cross certain biological barriers in the human body. During pregnancy, the placenta filters various substances before they reach the fetus. The question remains whether CBD can overcome this barrier and influence prenatal development. Once the child is born, the question then arises of whether CBD passes into breast milk during breastfeeding.
The official positions of health authorities on CBD, pregnancy and breastfeeding
Faced with the proliferation of over-the-counter CBD products, health authorities must provide clear recommendations to professionals and consumers. The analysis focuses on both pregnancy and breastfeedingtwoperiods when vigilance is paramount regarding any ingested substance.
What do international organizations say?
Several major institutions have been asked to take a position on the use of CBD during pregnancy and breastfeeding. To date, no international public health agency (WHO, FDA, EMA) formally approves or recommends the use of CBD during these sensitive periods. On the contrary, most of these authorities urge great caution, or even advise against the use of cannabis in any form when there is a possibility of prenatal or neonatal exposure.
To delve deeper into this topic, it is relevant to examine a detailed article on the potential benefits of CBD during pregnancy, including anti-inflammatory and analgesic effects, as well as relief from nausea and stress experienced by some pregnant or breastfeeding women.
What are the official recommendations in France and Europe?
In France, the National Agency for the Safety of Medicines and Health Products (ANSM) and other specialized organizations emphasize thelack of long-term dataon the potential risks to both pregnant women andbreastfed infants. The precautionary principle prevails, with a clear recommendation to avoid consuming CBD or cannabis-derived products during pregnancy and breastfeeding.
In the rest of Europe, the advice is similar. Countries like Germany, Belgium , and Switzerland are taking comparable, sometimes even stricter, measures. For them, the lack of longitudinal and controlled scientific studies makes it necessary to strongly prohibit or advise against any medically unsupervised use during these crucial stages of mother-child life.
Current knowledge: what scientific studies say
The body of direct research on CBD, pregnancy, and breastfeeding remains limited, which largely explains the caution displayed by health authorities. Questions concern both the bioavailability of CBD in pregnant womenand its potential effects on the baby, during gestation and after birth during breastfeeding.
Animal studies versus human trials
Numerous preliminary studies have been conducted on animal models . They show that CBD does indeed cross the placenta and could accumulate in certain fetal tissues. However, the extrapolation of these results to humans remains uncertain, as human physiology differs in several key aspects.
To date, the limited research conducted on humans has primarily focused on the overall effects of cannabis, without clearly isolating the action of CBD. The simultaneous presence of THC, a substance recognized as genotoxic and harmful to the baby's brain development, complicates the general interpretation. This lack of specificity represents a significant obstacle to establishing precise recommendations for CBD alone.
Potential risks highlighted
Despite the small number of targeted publications, some potential risks are mentioned. Among them:
- Altered neurological development in the fetus (extrapolated from effects observed with THC-rich cannabis)
- Birth weight and intrauterine growth
- Possible side effects transmitted via breast milk during breastfeeding
- Unknown risk to the baby's liver and immune system development
Some isolated studies describe a weak but perceptible transmission of cannabinoids into the infant's bloodstream. However, no formal evidence currently supports a direct toxicity of CBD alone. It is this persistent uncertainty that calls for extreme caution.
Comparative table: international positions on CBD and perinatal care
To clarify the different approaches, here is a summary table presenting the position of some health authorities on the safety of CBD exposure during pregnancy and breastfeeding :
| Country / organization | Pregnancy Recommendation | Breastfeeding recommendation |
|---|---|---|
| France (ANSM) | Not recommended / Precautionary principle | Not recommended / Avoid all CBD |
| United States (FDA) | Not recommended / Not enough data | Not recommended / Suspected risks |
| Germany (BfArM) | Prohibited except under the advice of a specialist medical professional. | Prohibited except for medical reasons |
| Switzerland (FOPH) | Not recommended / For medical use only | Not recommended / Use under professional supervision |
These opinions all point towards abstinence, except in exceptional circumstances validated by a qualified medical team. In short, no health authority currently encourages the unrestricted consumption of CBD during pregnancy or breastfeeding.
Frequently asked questions about CBD, pregnancy and breastfeeding
Why should CBD be avoided during pregnancy?
CBD ,while not producing psychoactive effects like THC, is an active compound in cannabis that can cross the placenta. This passage potentially exposes the fetus to substances whose long-term impact remains unknown. Health authorities therefore prioritize the baby's safety by recommending avoiding any exposure to CBD during this crucial period.
- Lack of sufficient scientific data on safety
- Mechanisms of action of CBD poorly understood in the fetus
- Prevention of potential risks of obstetric complications
Does CBD pass into breast milk during breastfeeding?
Studies suggest that some cannabinoids, including CBD, can be found in trace amounts in breast milk. This raises concerns about infant exposure and casts doubt on the safety of CBD during breastfeeding. Given this lack of certainty, official recommendations generally advise avoiding all CBD-containing products while breastfeeding.
- Limited human data
- Short- and long-term effects on the infant are unknown
- Difficulty in accurately quantifying the dose received by the baby
Are there any recommended natural alternatives for anxiety during pregnancy?
Rather than resorting to CBD or other cannabis, several natural strategies compatible with pregnancy and breastfeeding exist. Some practices are validated by scientific studies for reducing stress without risk to the baby. However, it is always advisable to consult a healthcare professional before making any changes to your routine.
- Adapted relaxation techniques (sophrology, prenatal yoga, meditation)
- Regular walks and gentle physical activity
- Emotional support from loved ones or support groups
What precautions should be taken before using a CBD product during the perinatal period?
Any decision to use CBD during pregnancy or breastfeeding should be discussed with a healthcare professional familiar with your medical history. Carefully reading the ingredients, avoiding self-medication, and choosing solutions with proven safety and efficacy are essential precautions when in a high-risk situation.
- Personalized medical assessment
- No substitution without specialized support
- Monitoring the origin and traceability of the product (if authorized use: exceptional medical cases)
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
